Leaflet TETAGAM P solution for injection in pre-filled syringe


Indicated for: prevention of tetanus

Route of administration: injectable

Substance: human tetanus immunoglobulin (immunoglobulin)

ATC: J06BB02 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Human tetanus immunoglobulin is a plasma-derived product used to prevent tetanus in individuals exposed to Clostridium tetani bacteria, usually through contaminated wounds. It provides passive immunity by supplying pre-formed antibodies against the tetanus toxin.

The medication is administered via intramuscular injection, as directed by a doctor.

Side effects may include pain at the injection site, fever, or allergic reactions. In rare cases, anaphylactic reactions may occur.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about TETAGAM P

  • Substance: human tetanus immunoglobulin
  • Date of last drug list: 01-08-2024
  • Commercial code: W67888001
  • Pharmaceutical form: solution for injection in pre-filled syringe
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: CSL BEHRING GMBH - GERMANIA
  • Holder: PRISUM INTERNATIONAL TRADING CO S.R.L. - ROMANIA
  • Number: 631/2021/01
  • Shelf life: 3 years